4th Molecular Diagnostics Summit 2016
Time：2016-06-22 -06-24location：hunan changshashi
Since 2010, Enmore Healthcare held IVD summits for 7 years, making the first high-end IVD industry summit in China. Since 2013, Enmore Healthcare focused on the molecular diagnostic markets, creating the MDx summit which based on the research and development of new technology and clinical transformation, promote cross-border exchanges and cooperation in the emerging market segment.
In 2015, genetic testing industry obtained a breakthrough in policy, technology, clinical and regulatory and further explored the molecular diagnostic technology in clinical application. At the same time, the liquid biopsy, next-next-generation sequencing technology, multiple sets of studies and such market is continuously exploring its clinical application. With the innovation of technology and market, it created a large number of new sequencing services, data service companies which provided industry with advanced technology and also spawned a new industry model.
Under this background, the 2016 4th MDx summit will focus on molecular diagnostic technology into clinical application and industry model innovation which will provide the latest clinical progress, cross-border exchange opportunities, jointly promote genetic testing industry.
